KMI
55
2
PEP
32
5
EXR
33
3
PGR
39
2
PRGO
53
2
SRE
56
2
EMC
63
-2
SLB
60
3
ISRG
69
-2
WFC
72
3
L
65
-2
BRK.B
43
5
AMGN
47
-2
JBHT
75
2
NOV
68
4
CNP
55
3
HSY
58
5
WHR
61
7
DOW
52
5
MLM
67
4
KMI
55
2
PEP
32
5
EXR
33
3
PGR
39
2
PRGO
53
2
SRE
56
2
EMC
63
-2
SLB
60
3
ISRG
69
-2
WFC
72
3
L
65
-2
BRK.B
43
5
AMGN
47
-2
JBHT
75
2
NOV
68
4
CNP
55
3
HSY
58
5
WHR
61
7
DOW
52
5
MLM
67
4
Financhill
Back

VYNE Therapeutics, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
56

VYNE
VYNE Therapeutics, Inc.

Last Price:
$0.57
Seasonality Move:
-5.82%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.24
Seasonality Move:
-11.9%
Buy
56
VYNE Therapeutics, Inc. (VYNE) is a Buy

Is VYNE Therapeutics, Inc. a Buy, Sell or Hold?

  • The current VYNE Therapeutics, Inc. [VYNE] share price is $0.57. The Score for VYNE is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • VYNE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VYNE Stock Price Chart

What is VYNE Therapeutics, Inc.'s stock price today?

  • The VYNE Therapeutics, Inc. share price today is $0.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VYNE is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

VYNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: -126003 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.39 - 0.59) Buy
Bollinger Bands (100): (0.3 - 0.46) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

VYNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Buy
20-day SMA: 0.52 Buy
50-day SMA: 0.42 Buy
200-day SMA: 0.8 Sell
8-day EMA: 0.55 Buy
20-day EMA: 0.43 Buy
50-day EMA: 0.25 Buy
200-day EMA: 0.08 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

VYNE Therapeutics, Inc. Earnings Growth & VYNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and a decrease next year of $0.55 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

VYNE Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):